Lv3
320 积分 2025-01-09 加入
Why Does EGFR-Targeted Therapy Continue to Fail in Breast Cancer? From Mechanistic Deciphering to Novel Intervention Strategies
4天前
已完结
Why Does EGFR-Targeted Therapy Continue to Fail in Breast Cancer? From Mechanistic Deciphering to Novel Intervention Strategies
23天前
已关闭
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
3个月前
已完结
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
3个月前
已完结
Development of Dual-Receptor Lysosome-Targeting Chimeras for Protein Degradation
3个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4个月前
已完结
The interferon regulatory factors and oncogenesis
5个月前
已完结
Ubiquitination modification: critical regulation of IRF family stability and activity
5个月前
已完结
The phase II MutHER study of neratinib alone and in combination with fulvestrant in HER2 mutated, non-amplified metastatic breast cancer
7个月前
已完结
The phase II MutHER study of neratinib alone and in combination with fulvestrant in HER2 mutated, non-amplified metastatic breast cancer
7个月前
已完结
皖公网安备34019202002308
